Nuclear FOXM1 drives chemoresistance in AML

Leukemia. 2017 Jan;31(1):251-255. doi: 10.1038/leu.2016.270. Epub 2016 Oct 3.

Authors

I Khan¹, M Halasi², M F Zia¹, P Gann³, S Gaitonde³, N Mahmud¹, A L Gartel²

Affiliations

¹ Division of Hematology/Oncology, University of Illinois, Chicago, IL, USA.
² Division of Gastroenterology/Hepatology, Department of Medicine,University of Illinois, Chicago, IL, USA.
³ Division of Research Histology and Tissue Imaging Core, University of Illinois, Chicago, IL, USA.

PMID: 27694928
DOI: 10.1038/leu.2016.270

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Cell Line, Tumor
Drug Resistance, Neoplasm*
Forkhead Box Protein M1 / metabolism
Forkhead Box Protein M1 / physiology*
Humans
Leukemia, Myeloid, Acute / physiopathology*
Nuclear Proteins / metabolism
Nuclear Proteins / physiology*
Nucleophosmin
Protein Binding

Substances

Forkhead Box Protein M1
Nuclear Proteins
Nucleophosmin

Grants and funding